Latest Leber's hereditary optic neuropathy Stories
RnRMarketResearch.com adds “Optic Neuropathy Global Clinical Trials Review, H1, 2015” report to its store.
A research team, led by John Guy, M.D., professor of ophthalmology at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has pioneered a novel technological treatment for Leber Hereditary Optic Neuropathy (LHON), an inherited genetic defect that causes rapid, permanent, and bilateral loss of vision in people of all ages, but primarily males ages 20-40.
A clinical trial led by Newcastle University shows that the drug, idebenone (CatenaÂ®), improved the vision and perception of colour in patients with Leber's Hereditary Optic Neuropathy (LHON).
A clinical trial led by Newcastle University shows that the drug, idebenone improved the vision and perception of color in patients with Leber's Hereditary Optic Neuropathy (LHON).
PINE BROOK, N.J., March 28, 2011 /PRNewswire/ -- Diopsys, Inc. has launched the new DiopsysÂ® NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders.
Researchers believe they have found a way to avoid certain genetically inherited disorders through a special kind of in vitro fertilization (IVF).
- A serpent whose bite was fabled to produce intense thirst.